HIV
Clinical trials for HIV explained in plain language.
Never miss a new study
Get alerted when new HIV trials appear
Sign up with your email to follow new studies for HIV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental HIV vaccine trial halted early – what we know
⭐️ VACCINE ⭐️ TerminatedThis early-stage study tested whether a new HIV vaccine was safe and could trigger an immune response in healthy adults aged 18 to 50. The vaccine was given alone or with other HIV vaccines in different schedules. The study was terminated early, so results are limited.
Matched conditions: HIV
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:54 UTC
-
HIV antibody monotherapy trial seeks virus suppression without daily pills
Disease control TerminatedThis study tested whether a monoclonal antibody called PRO 140 could keep HIV under control when used alone, replacing standard combination antiretroviral therapy (ART). Twenty adults with HIV who had completed a prior study without virus rebound were enrolled. The main goal was …
Matched conditions: HIV
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 16, 2026 21:18 UTC
-
Texts and peer support aim to help trans women suppress HIV
Disease control TerminatedThis study tested whether text messages, one-on-one peer support, or both could help transgender women with HIV reach undetectable viral levels. About 71 women took part and received either daily texts, peer navigation sessions, or both for three months. The goal was to find the …
Matched conditions: HIV
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 16, 2026 21:17 UTC
-
Study tests smarter HIV prevention for LGBTQ+ people struggling with addiction
Prevention TerminatedThis study aimed to help HIV-negative transgender women and men who have sex with men who also have a substance use disorder stay on PrEP, a daily pill that prevents HIV. Participants received counseling and text support, with extra help for those still struggling. The study was …
Matched conditions: HIV
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Prevention
Last updated May 16, 2026 21:15 UTC
-
Website aims to boost HIV home testing and PrEP access for black women in texas hotspots
Prevention TerminatedThis study tested a website designed to help Black women in Texas cities order free HIV and STI home tests, use them, and get linked to treatment or PrEP if needed. The goal was to make testing easier and faster for women who hadn't tested in the past year. The study ended early …
Matched conditions: HIV
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated May 15, 2026 11:55 UTC
-
CBD trial for emotional blindness in HIV patients shows promise
Symptom relief TerminatedThis study tested whether cannabidiol (CBD) can help people living with HIV who have alexithymia—a condition that makes it hard to recognize and describe emotions. Participants took either CBD or a placebo for 4 weeks. The goal was to see if CBD improves emotional awareness and r…
Matched conditions: HIV
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Can a text or video nudge boost HIV retesting? pilot study aims to find out
Knowledge-focused TerminatedThis pilot study tested several low-cost behavioral nudges—like text messages and videos—to encourage HIV retesting among adults at higher risk of infection in rural Kenya and Uganda. The goal was to see which approaches were acceptable and feasible, and to refine them for a futu…
Matched conditions: HIV
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 16, 2026 21:14 UTC